Cotterill SJ, Ahrens S, Paulussen M, Jurgens HF, Voute PA, Gadner H, Craft AW.
Prognostic Factors in Ewing's Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing's Sarcoma Study Group.
J Clin Oncol 2000; 18(17): 3108-3114Cotterill SJ, Parker L, Malcolm AJ, Reid M, More L, Craft AW.
Incidence and Survival for cancer in children and young adults in the Northern Region Young Person’s Malignant Disease Registry.
Br J Cancer. 2000; 83(3): 397-403Cotterill SJ, Pearson AD, Pritchard J, Foot AB, Roald B, Kohler JA, Imeson J
Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992.
Eur J Cancer 2000;36(7):901-908Skinner R, Cotterill SJ, Stevens MCG.
Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG late effects group study.
Br J Cancer. 2000; 82(10): 1636-1645.Estlin EJ, Cotterill S, Pratt CB, Pearson ADJ, Bernstein M.
Phase I Trials in Pediatric Oncology: Perceptions of Pediatricians From the United Kingdom Children's Cancer Study Group and the Pediatric Oncology Group.
J Clin Oncol 2000;18(9):1900-1905.Shankar AG, Pinkerton CR, Atra A, Ashley S, Lewis I, Spooner D, Cannon S, Grimer R, Cotterill SJ, Craft AW.
Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG).
Eur J Cancer. 1999 Nov;35(12):1698-704.Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F.
Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
N Engl J Med. 1999 Jun 24;340(25):1954-61.Craft A, Cotterill S, Malcolm A, Spooner D, Grimer R, Souhami R, Imeson J, Lewis I.
Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study.
J Clin Oncol. 1998 Nov;16(11):3628-33Lastowska M, Cotterill S, Pearson AD, Roberts P, McGuckin A, Lewis I, Bown N.
Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. U.K. Children's Cancer Study Group and the U.K. Cancer Cytogenetics Group.
Eur J Cancer. 1997 Sep;33(10):1627-33Craft AW, Cotterill SJ, Bullimore JA, Pearson D.
Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party.
Eur J Cancer. 1997 Jun;33(7):1061-9.Saha V, Eden OB, Hann I, Attard-Montalto S, Cotterill S, Carter R.
Primary extra-thoracic T-cell non-Hodgkin's lymphoma of childhood. The United Kingdom Children's Cancer Study Group.
Leukemia 1995 Jan;9(1):40-3Pritchard J, Imeson J, Barnes J, Cotterill S, Gough D, Marsden HB, Morris-Jones P, Pearson D.
Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study.
J Clin Oncol 1995 Jan;13(1):124-33Craft A.W., Cotterill S., Imeson J.
Improvement in survival for Ewing's sarcoma by substitution of Ifosfamide for Cyclophosphamide
American Journal of Paediatric Oncology. 1993; 15:S31-S35.Eden OB, Hann I, Imeson J, Cotterill S, Gerrard M, Pinkerton CR.
Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503.
Br J Haematol. 1992 Oct;82(2):310-6